Cleared Traditional

K942024 - PORT-A-CATH LOW PROFILE IMPLANTABLE VEN...

K942024 is the FDA 510(k) clearance for PORT-A-CATH LOW PROFILE IMPLANTABLE VEN... by Pharmacia Deltec, Inc.. It is a Class 2 General Hospital device (product code LJT) cleared through the Traditional 510(k) pathway after a 91-day FDA review.

K942024 · Pharmacia Deltec, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1994
Decision
91d
Days
Class 2
Risk

K942024 is an FDA 510(k) clearance for the PORT-A-CATH LOW PROFILE IMPLANTABLE VENOUS ACCESS SYSTEM. Classified as Port & Catheter, Implanted, Subcutaneous, Intravascular (product code LJT), Class II - Special Controls.

Submitted by Pharmacia Deltec, Inc. (St. Paul, US). The FDA issued a Cleared decision on July 26, 1994 after a review of 91 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5965 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Pharmacia Deltec, Inc. devices

Submission Details

510(k) Number K942024 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 26, 1994
Decision Date July 26, 1994
Days to Decision 91 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 129d · This submission: 91d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5965
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

All 121
Devices cleared under the same product code (LJT) and FDA review panel - the closest regulatory comparables to K942024.
CELSITE VENOUS SYSTEM
K952548 · B.Braun Medical, Inc. · Jul 1995
STRATO MEDICAL LIFEPORT LPS 7515
K942848 · Strato Medical Corp. · Feb 1995
STRATO MEDICAL INFUSE-A-PORT/INFUSE-A-KIT PERIPORT PERIPHERAL ACCESS SYSTEM
K934518 · Strato Medical Corp. · Jan 1995
IPI DUAL LUMEN PORT
K934167 · Pudenz-Schulte Medical Research Corp. · Jul 1994
IPI LOW PROFILE IMPORT
K934796 · Pudenz-Schulte Medical Research Corp. · Jul 1994
PS MEDICAL IPI ACCESS KIT
K930206 · Pudenz-Schulte Medical Research Corp. · Feb 1994